Football
Dembele agrees new 2-year Barcelona contract
FC Barcelona has confirmed that Ousmane Dembele has agreed on a new two-year contract to stay at Camp Nou.
The five-year contract that Dembele signed when he joined Barca from Borussia Dortmund in 2017 expired at the end of June.
Talks have continued over a new deal and the France international has now agreed terms on a fresh contract, keeping him at Barca until the end of the 2023-24 season.
That Dembele remains a Barca player at all is a complete turnaround from the situation in January.
The club insisted the winger would be sold or leave on a free transfer at the end of the campaign after the 25-year-old turned down a contract offer.
The LaLiga club revealed he will sign his new deal at the Ciutat Esportiva Joan Gamper later on Thursday.
Barca president Joan Laporta revealed on Wednesday that Dembele’s new contract will be confirmed this week.
Dembele has made 150 appearances for Barca and came to the fore last season, setting up 13 goals in LaLiga – more than any other player in the Spanish top flight.
The Blaugrana also reached an agreement to sign Brazil winger Raphinha from Leeds United for a reported fee of €($) 67 million. Rafinha arrived in Spain for a medical on Wednesday.
-
Football7 days agoBallon d’Or 2026: Yamal, Mbappe, Kane emerge early favourites
-
Football6 days agoPost-World Cup Shake-Up: Managerial changes, record transfers dominate football headlines
-
Football6 days agoWAFCON 2026: Super Falcons target winning start as Nigeria face debutants Malawi
-
Energy5 days agoNigeria wastes enough gas to Ggenerate 62,400GWh of electricity amid deepening energy crisis — NOSDRA
-
Latest1 week agoAccountability group questions ₦962.8bn Allocation for empowerment projects, official vehicles in 2026 budget
-
Business2 days agoCooking gas dealers slash prices amid intensifying market competition
-
Business2 days agoInformation Minister, VON DG to lead ARCON’s 2026 Advertising Industry Colloquium
-
Health5 days agoFauci’s personal diaries fuel renewed scrutiny of COVID-19 vaccine safety


